Search

everythinglearnresearchcommunity

for

Search:↓

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

The research found that MRI and certain hormone levels can help tell apart ovarian tumors from hyperthecosis in postmenopausal women, but tissue analysis is still needed for a definite diagnosis.

Different sPLA2 enzymes affect immunity, skin and hair health, reproduction, and may be potential targets for therapy.

Spironolactone may help reduce hair loss in androgenic alopecia.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Testosterone changes important cell communication proteins in pregnant rats' uteruses, which might affect pregnancy success.

Electric pulse treatments for breast cancer show promise in being safer and more effective, with fewer side effects.

AGA is a common hair loss disorder, and early diagnosis and treatment with minoxidil or finasteride can help reduce emotional distress.

The conference concluded that understanding hair and nail disorders is important, iron deficiency may be linked to hair loss, and while some treatments for skin conditions are effective, they may have risks and high costs.

Testosterone increases acidification in the vas deferens by up-regulating V-ATPase.

Cinnamon may help manage obesity and improve conditions related to Polycystic Ovary Syndrome (PCOS).

Women with irregular periods and/or excessive body hair are more likely to have polycystic ovaries, and this condition is linked to higher health risks.

Two new reliable Arabic questionnaires for measuring quality of life in women with PCOS were created, one for married and one for unmarried women.

Different treatments for PCOS should be tailored to the individual, including lifestyle changes and various medications.

Topical finasteride cream reduces hair growth perception in women with idiopathic hirsutism.

Non-classical 21 hydroxylase deficiency is an underdiagnosed cause of female hair loss and polycystic ovarian syndrome.

Both oral contraceptives reduced hirsutism in PCOS patients, but adding metformin showed no extra benefit.

Myo-inositol-based treatments greatly improve pregnancy chances for women with PCOS.

Oxidative stress worsens PCOS by damaging cells and disrupting metabolism, suggesting antioxidant treatments might help.

Women with PCOS are more likely to experience sexual dysfunction, but lifestyle changes and weight loss can improve sexual function.

The 5% minoxidil lotion without propylene glycol is effective, well-tolerated, and cosmetically acceptable for hair loss.

Finasteride helps induce ovulation in nonresponder PCOS women.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Diane 35 plus finasteride is more effective in reducing hair growth and androgen levels, but may decrease libido.

Finasteride effectively treats hirsutism in women, but more research needed for long-term results.

Insulin resistance is significantly linked to a higher risk of depression in women with PCOS.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

Intermittent low-dose finasteride works as well as daily use for treating excessive hair growth in women.

The N363S gene variant does not cause higher adrenal androgen levels in women with polycystic ovary syndrome.